Literature DB >> 33969153

A cross sectional study of the risk factors of hepatitis C infection in North Egypt.

Soad S Mandoh1, Kholoud Ayman1, Ahmed Elbardakheny1, Hala Raaft1, Ahmed A Ibrahim1, Rasha Alsaeed Alshaikh2, Fotouh R Mansour3,4.   

Abstract

Hepatitis C is a viral infection that has been declared as a global health problem by the World Health Organization. Egypt has the highest prevalence of hepatitis C virus (HCV) which results in a high morbidity and mortality from chronic liver disease, cirrhosis, and even hepatocellular carcinoma. Cities have lower rates of infection than rural areas. Studies about the abnormally high prevalence of HCV in Egypt ascribed that to the governmental campaign to treat Schistosoma. However, these treatment campaigns have stopped more than 35 years ago, which means that some other modes of transmission must have been involved. The objective of this work is to study the main reasons of HCV prevalence in the Egyptian Delta valley. A questionnaire-based study was conducted by members of the HCV Fighters project. Responses were collected from 949 volunteers (451 HCV patients and 498 healthy volunteers as control). The data were analyzed using SPSS version 19.0. The two-sample proportion test was used for statistical comparison between groups. The most probable risk factors of HCV transmission in Egypt included regular visits to dental clinics (55.2%), previous surgical operations (54.4%), former blood transfusion (52%), intrafamilial HCV infection (45.9%) and history of bilharzial infection (44.3%). Increasing public awareness about modes of transmission and risk factors of HCV infection is a must, especially within family members of HCV patients. Strict commitment to proper medical care precautions by health care practitioners is required. © Indian Virological Society 2021.

Entities:  

Keywords:  Dental clinics; Egypt; Hepatitis C virus; Prevalence; Risk factors; Surgical operations

Year:  2021        PMID: 33969153      PMCID: PMC8093146          DOI: 10.1007/s13337-020-00639-2

Source DB:  PubMed          Journal:  Virusdisease        ISSN: 2347-3584


  24 in total

1.  Risk factors for dialysis-associated hepatitis C in Venezuela.

Authors:  G Y Muller; M E Zabaleta; A Arminio; C J Colmenares; F I Capriles; N E Bianco; I V Machado
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

Review 2.  Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-12-16

Review 3.  Global epidemiology and burden of HCV infection and HCV-related disease.

Authors:  Aaron P Thrift; Hashem B El-Serag; Fasiha Kanwal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

4.  Transmission of hepatitis C virus in a gynecological surgery setting.

Authors:  M Massari; N Petrosillo; G Ippolito; L Solforosi; L Bonazzi; M Clementi; A Manzin
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

5.  Hepatitis C virus status in hemodialysis patients in Menoufia Government, Egypt, five years apart: Do we have any improvement?

Authors:  Khaled Mohamed Amin Elzorkany; Ahmed Zahran
Journal:  Saudi J Kidney Dis Transpl       Date:  2017 Sep-Oct

Review 6.  Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review.

Authors:  Daniele Prati
Journal:  J Hepatol       Date:  2006-07-25       Impact factor: 25.083

7.  The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt.

Authors:  C Frank; M K Mohamed; G T Strickland; D Lavanchy; R R Arthur; L S Magder; T El Khoby; Y Abdel-Wahab; E S Aly Ohn; W Anwar; I Sallam
Journal:  Lancet       Date:  2000-03-11       Impact factor: 79.321

8.  Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.

Authors:  Magdy El Ekiaby; Faten Moftah; Heidi Goubran; Harry van Drimmelen; Syria LaPerche; Steve Kleinman; Michael Busch; Nico Lelie
Journal:  Transfusion       Date:  2015-03-13       Impact factor: 3.157

9.  Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico.

Authors:  Nahum Méndez-Sánchez; Daniel Motola-Kuba; Norberto C Chavez-Tapia; Jesús Bahena; Ricardo Correa-Rotter; Misael Uribe
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

10.  Global distribution and prevalence of hepatitis C virus genotypes.

Authors:  Jane P Messina; Isla Humphreys; Abraham Flaxman; Anthony Brown; Graham S Cooke; Oliver G Pybus; Eleanor Barnes
Journal:  Hepatology       Date:  2014-07-28       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.